Skip to main content

Table 4 Population attributable risk of all-cause mortality and CVD hospitalization, associated to HbA1c > 6.5%

From: Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study

 

All-cause mortality

CHD hospitalization

Stroke hospitalization

Cases/Non-cases

499/18,598

912/18,185

786/18,311

RR

1.29 (1.08, 1.55)

1.38 (1.2, 1.59)

1.05 (0.91, 1.21)

PAR %

13.62 (3.96, 22.90)

17.90 (10.53, 25.20)

2.64 (−5.51, 10.76)

  1. Model is fully adjusted for age (restricted quadratic splines with 5 knots), sex, smoking status (never, former, current), obesity (no, yes), hypertension (no, yes), chronic kidney disease (no, yes), anti-hypertensive medication (no, yes), glucose lowering medication (no, yes), lipid lowering medication (no, yes). The prevalence of glycated hemoglobin > 6.5% was 57.78%
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us